Ipamorelin & Tesamorelin Blend
Two-Component Lyophilized Peptide Blend: Ipamorelin and Tesamorelin
Mass per vial on the lot certificate · 99.0% pure · COA ✓
Two-component research blend supplied as a single lyophilized aliquot containing Ipamorelin and Tesamorelin. Per-component mass is confirmed on the certificate of analysis for the lot supplied.
SPEC Ipamorelin & Tesamorelin Blend specifications
| Full name | Two-Component Lyophilized Peptide Blend: Ipamorelin and Tesamorelin |
|---|---|
| Quantity / vial | Mass per vial on the lot certificate |
| CAS number | Reported on the lot certificate |
| Molecular formula | Reported on the lot certificate |
| Molecular weight | Reported on the lot certificate |
| Sequence / identity | Reported on the lot certificate |
| Purity | Reported on the lot certificate (method stated on the lot certificate) |
| Form | Lyophilized powder |
| Testing | Independent third-party laboratory, per lot |
| Category | Growth Hormone Secretagogues |
BLEND Composition
Every component and its mass is stated per vial. Where a per-component split is not fixed on the supplier documentation, the value is reported on the lot certificate rather than estimated here.
| Component | Mass / vial | Sequence / identity | CAS |
|---|---|---|---|
| Ipamorelin | — | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | 170851-70-4 |
| Tesamorelin | — | Reported on the lot certificate | Reported on the lot certificate |
PROOF 1 Methods & current-lot COA
The published certificate for the current lot is backed by RP-HPLC (purity) and LC-MS (identity), performed by Janoshik, an independent third-party laboratory. Each COA reports identity, purity, and net content for that specific lot.
PROOF 2 Compliance & documents
Sold exclusively for in-vitro laboratory research and analytical use — not for human or animal use. Full scope on our compliance page. Spec sheets, safety documentation, and full COA packages are issued on request.
PROOF 3 Verify & reorder
Already have a vial? Enter its lot to pull the exact COA.
HANDLING Material handling & storage
Lyophilized powder. General laboratory handling for lyophilized material: keep vials cold, protected from light and moisture, and minimize freeze–thaw cycles. Treat as material-handling information, not a specification — follow your own lab's protocols and any lot-specific note on the COA.
REF Literature note
Published scientific literature exists for this compound and can be located through public databases such as PubMed. This is stated for identification and bibliographic completeness only; it is not a representation of any outcome, effect, or benefit. Specific citations are populated only where each reference has been verified.
NOTES Buyer notes (moderated)
Buyer notes are moderated to packaging, label accuracy, COA clarity, and shipping. We do not publish notes describing use, effects, or outcomes, and we do not publish a note we cannot tie to a real order.
BPC-157, GHK-Cu, KPV & TB-500 Blend
Four-component blend: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, KPV 10 mg. 80 mg total. Lyophilized powder.
BPC-157, GHK-Cu & TB-500 Blend
Three-component blend: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg. 70 mg total. Lyophilized powder.
BPC-157 & TB-500 Blend
Two-component blend: BPC-157 10 mg, TB-500 10 mg. 20 mg total per vial. Lyophilized powder.